There are 16 resources available
Welcome and Introduction
Presenter: M.J. Ahn, KR
Session: Welcome and Introduction
Resources:
Slides
Webcast
The structure, function and role of KRAS in normal cell homeostasis
Presenter: M. Barbacid, ES
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Epidemiology of KRAS activating mutations: Incidence and biology across tumours with emphasis on lung cancer
Presenter: T. Seto, JP
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Molecular landscape of KRAS mutant NSCLC (molecular concomitant genetic alterations in KRAS mutant tumours)
Presenter: S.H. Lee, KR
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Pathology and molecular testing of NSCLC for KRAS mutations: who, how and when? (tissue, liquid biopsy)
Presenter: K. M. Kerr, UK
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Clinical development of KRAS G12C inhibitors – where are we now?
Presenter: Z. Li, CN
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Resistance to KRAS G12C inhibitors – what do we know?
Presenter: D. S. W. Tan, SG
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Moving forward with KRAS G12C inhibitors – combinations (only chemotherapy and targeted therapy sequencing)
Presenter: F. Skoulidis, US
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Combination Therapy
Presenter: D. S. W. Tan, SG
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Webcast
Single agent case with Liver Toxicity
Presenter: Z. Li, CN
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast